Reported covered position: Legislative Correspondent, U. S. Sen. Chris Bond
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
S. 3187, Food and Drug Administration Safety and Innovation Act; H. R. 4095, Online Pharmacy Safety Act; S. 2002, Online Pharmacy Safety Act; Issues related to telehealth reimbursement and telehealth licensing for providers..
H. R. 5651, Food and Drug Administration Reform Act; S. 3187, Food and Drug Administration Safety and Innovation Act; H. R. 4095, Online Pharmacy Safety Act; S. 2002, Online Pharmacy Safety Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INTERNATIONAL STEM CELL CORPORATION via ML STRATEGIES, LLC
2013 · first_quarter · 1@
General issues relating to federal regulation and funding of stem cell research.
INTERNATIONAL STEM CELL CORPORATION via ML STRATEGIES, LLC
2013 · first_quarter · Q1
Source: Senate LDA
Food and Drug Administration Reform Act of 2012
Client: AMERICAN WELL CORPORATION · Firm: ML STRATEGIES, LLC
H. R. 5651, Food and Drug Administration Reform Act; S. 3187, Food and Drug Administration Safety and Innovation Act; H. R. 4095, Online Pharmacy Safety Act; S. 2002, Online Pharmacy Safety Act.
Telehealth Promotion Act of 2012
Client: AMERICAN WELL CORPORATION · Firm: ML STRATEGIES, LLC
S. 3187, Food and Drug Administration Safety and Innovation Act; S. 2002, Online Pharmacy Safety Act; Issues related to telehealth reimbursement and telehealth licensing for providers; H.R. 6719, Telehealth Promotion Act of 2012.
General issues relating to federal regulation and funding of stem cell research.
BLUE CROSS BLUE SHIELD OF MICHIGAN via ML STRATEGIES, LLC
2013 · first_quarter · Q1
General issues related to Affordable Care Act implementation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of
AMEDISYS HOME HEALTH SERVICES via ML STRATEGIES, LLC
2013 · first_quarter · Q1
Issues pertaining to home health services; bundled payment initiatives with the federal government; the sustainable growth rate formula; health information technology and telehealth, and Medicare/Medicaid Demonstration Projects.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN WELL CORPORATION via ML STRATEGIES, LLC
2013 · first_quarter · Q1
General issues related to TeleHealth.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMEDISYS HOME HEALTH SERVICES via ML STRATEGIES, LLC
2012 · fourth_quarter · Q4
Issues pertaining to home health services; bundled payment initiatives with the federal government; the sustainable growth rate formula; health information technology and telehealth, and Medicare/Medicaid Demonstration Projects.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL STEM CELL CORPORATION via ML STRATEGIES, LLC
2012 · fourth_quarter · Q4
General issues relating to federal regulation and funding of stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN WELL CORPORATION via ML STRATEGIES, LLC
2012 · fourth_quarter · Q4
S. 3187, Food and Drug Administration Safety and Innovation Act; S. 2002, Online Pharmacy Safety Act; Issues related to telehealth reimbursement and telehealth licensing for providers; H.R. 6719, Telehealth Promotion Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS BLUE SHIELD OF MICHIGAN via ML STRATEGIES, LLC
2012 · fourth_quarter · Q4
Issues related to health and insurance exchanges, essential health benefits package, preventive services coverage, consumer owned and operated plans, multi-state plans, wellness programs, and screening requirements for managed care organizations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMEDISYS HOME HEALTH SERVICES via ML STRATEGIES, LLC
2012 · third_quarter · Q3
Issues pertaining to home health services; bundled payment initiatives with the federal government; the sustainable growth rate formula; health information technology, and Medicare/Medicaid Demonstration Projects.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
AMERICAN WELL CORPORATION via ML STRATEGIES, LLC
2012 · third_quarter · Q3
S. 3187, Food and Drug Administration Safety and Innovation Act; H. R. 4095, Online Pharmacy Safety Act; S. 2002, Online Pharmacy Safety Act; Issues related to telehealth reimbursement and telehealth licensing for providers..
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS BLUE SHIELD OF MICHIGAN via ML STRATEGIES, LLC
2012 · third_quarter · Q3
Issues related to health and insurance exchanges, essential health benefits package, preventive services coverage, consumer owned and operated plans, multi-state plans, wellness programs, and screening requirements for managed care organizations.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL STEM CELL CORPORATION via ML STRATEGIES, LLC
2012 · third_quarter · Q3
General issues relating to federal regulation and funding of stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
INTERNATIONAL STEM CELL CORPORATION via ML STRATEGIES, LLC
2012 · second_quarter · Q2
General issues relating to federal regulation and funding of stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
BLUE CROSS BLUE SHIELD OF MICHIGAN via ML STRATEGIES, LLC
2012 · second_quarter · Q2
Issues related to health and insurance exchanges, essential health benefits package, preventive services coverage, medical loss ratio, consumer owned and operated plans, multi-state plans, wellness programs, and screening requirements for managed care organizations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN WELL CORPORATION via ML STRATEGIES, LLC
2012 · second_quarter · Q2
H. R. 5651, Food and Drug Administration Reform Act; S. 3187, Food and Drug Administration Safety and Innovation Act; H. R. 4095, Online Pharmacy Safety Act; S. 2002, Online Pharmacy Safety Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMEDISYS HOME HEALTH SERVICES via ML STRATEGIES, LLC
2012 · second_quarter · Q2
Issues pertaining to home health services; bundled payment initiatives with the federal government; the sustainable growth rate formula; health information technology, and Medicare/Medicaid Demonstration Projects.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN WELL CORPORATION via ML STRATEGIES, LLC
2012 · second_quarter · RR
General issues pertaining to health information technology.
INTERNATIONAL STEM CELL CORPORATION via ML STRATEGIES, LLC
2012 · first_quarter · Q1
General issues relating to federal regulation and funding of stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE